세계의 심장 모니터링 및 심장 박동 관리 디바이스 시장(2024-2028년)

The cardiac monitoring and cardiac rhythm management devices market is forecasted to grow by USD 7476.72 mn during 2023-2028, accelerating at a CAGR of 5.38% during the forecast period. The report on the cardiac monitoring and cardiac rhythm management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cvds globally, technological advances in cm and crm devices, and increasing uptake of mobile cardiac telemetry (mct).

Technavio's cardiac monitoring and cardiac rhythm management devices market is segmented as below:

By Product

• CRM devices
• CM devices

By End-user

• Hospitals
• clinics
• Cardiac care centers
• ASCs

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing strategic initiatives by market vendors as one of the prime reasons driving the cardiac monitoring and cardiac rhythm management devices market growth during the next few years. Also, growing focus on developing integrated arrhythmia-monitoring devices and increasing utilization of cardiac implants will lead to sizable demand in the market.

The report on the cardiac monitoring and cardiac rhythm management devices market covers the following areas:

• Cardiac monitoring and cardiac rhythm management devices market sizing
• Cardiac monitoring and cardiac rhythm management devices market forecast
• Cardiac monitoring and cardiac rhythm management devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiac monitoring and cardiac rhythm management devices market vendors that include Abbott Laboratories, Adaptive Biotechnologies Corp., Asahi Kasei Corp., BIOTRONIK SE and Co. KG, Boston Scientific Corp., BPL MEDICAL TECHNOLOGIES Pvt. Ltd., Cell Microsystems Inc., GE Healthcare Technologies Inc., Johnson and Johnson, Koninklijke Philips N.V., Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., Osypka Medical GmBH, Progetti srl, QIAGEN NV, SCHILLER AG, Stryker Corp., ZOLL Medical Corp., and Shree Pacetronix Ltd.. Also, the cardiac monitoring and cardiac rhythm management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global cardiac monitoring and cardiac rhythm management devices market 2018 - 2022
• 4.2 Product Segment Analysis 2018 - 2022
• 4.3 End-user Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Product

• 6.1 Market segments
• 6.2 Comparison by Product
• 6.3 CRM devices - Market size and forecast 2023-2028
• 6.4 CM devices - Market size and forecast 2023-2028
• 6.5 Market opportunity by Product

7 Market Segmentation by End-user

• 7.1 Market segments
• 7.2 Comparison by End-user
• 7.3 Hospitals and clinics - Market size and forecast 2023-2028
• 7.4 Cardiac care centers and ASCs - Market size and forecast 2023-2028
• 7.5 Market opportunity by End-user

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 Germany - Market size and forecast 2023-2028
• 9.9 UK - Market size and forecast 2023-2028
• 9.10 Canada - Market size and forecast 2023-2028
• 9.11 China - Market size and forecast 2023-2028
• 9.12 Market opportunity by geography

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Abbott Laboratories
• 12.4 Asahi Kasei Corp.
• 12.5 BIOTRONIK SE and Co. KG
• 12.6 Boston Scientific Corp.
• 12.7 BPL MEDICAL TECHNOLOGIES Pvt. Ltd.
• 12.8 GE Healthcare Technologies Inc.
• 12.9 Koninklijke Philips N.V.
• 12.10 Medtronic Plc
• 12.11 MicroPort Scientific Corp.
• 12.12 Nihon Kohden Corp.
• 12.13 Progetti srl
• 12.14 SCHILLER AG
• 12.15 Shree Pacetronix Ltd.
• 12.16 Stryker Corp.
• 12.17 ZOLL Medical Corp.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations